`Q5122` Inj, nyvepria

Injection, pegfilgrastim-apgf (nyvepria), biosimilar, 0.5 mg

Medicare coverage: Carrier judgment
Status: active (July 2026 file)
MUE: max 12 units per day (practitioner), rationale: Prescribing Information